Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
afatinib
1200.123
NCT01466660
Lung Neoplasms
Phase 2
 
October 2017

Powered by ideaPoint, Inc.